Found: 33
Select item for more details and to access through your institution.
Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 8, p. 2116, doi. 10.1210/clinem/dgae048
- By:
- Publication type:
- Article
Index60 as an additional diagnostic criterion for type 1 diabetes.
- Published in:
- Diabetologia, 2021, v. 64, n. 4, p. 836, doi. 10.1007/s00125-020-05365-4
- By:
- Publication type:
- Article
Impact of Body Mass Index on Growth in Boys with Delayed Puberty.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2006, v. 19, n. 8, p. 971, doi. 10.1515/jpem.2006.19.8.971
- By:
- Publication type:
- Article
The effect of glucagon-like Peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents With Severe Obesity.
- Published in:
- JAMA Pediatrics, 2013, v. 167, n. 4, p. 355, doi. 10.1001/jamapediatrics.2013.1045
- By:
- Publication type:
- Article
Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry.
- Published in:
- Pediatric Diabetes, 2016, v. 17, n. 1, p. 15, doi. 10.1111/pedi.12231
- By:
- Publication type:
- Article
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies.
- Published in:
- Diabetes Care, 2023, v. 46, n. 5, p. 1098, doi. 10.2337/dc22-2236
- By:
- Publication type:
- Article
Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening.
- Published in:
- Diabetes Care, 2022, v. 45, n. 12, p. 2982, doi. 10.2337/dc22-1362
- By:
- Publication type:
- Article
The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impaired Fasting Glucose in Cystic Fibrosis.
- Published in:
- Diabetes Care, 2010, v. 33, n. 12, p. 2660, doi. 10.2337/dc10-0613
- By:
- Publication type:
- Article
Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Meal replacements followed by topiramate for the treatment of adolescent severe obesity: A pilot randomized controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association of Osteocalcin With Obesity, Insulin Resistance, and Cardiovascular Risk Factors in Young Adults.
- Published in:
- Obesity (19307381), 2012, v. 20, n. 11, p. 2194, doi. 10.1038/oby.2012.108
- By:
- Publication type:
- Article
Exenatide as a Weight-Loss Therapy in Extreme Pediatric Obesity: A Randomized, Controlled Pilot Study.
- Published in:
- Obesity (19307381), 2012, v. 20, n. 2, p. 364, doi. 10.1038/oby.2011.337
- By:
- Publication type:
- Article
Postprandial Endothelial Function, Inflammation, and Oxidative Stress in Obese Children and Adolescents.
- Published in:
- Obesity (19307381), 2011, v. 19, n. 6, p. 1279, doi. 10.1038/oby.2010.318
- By:
- Publication type:
- Article
Bone mineral density and body composition in children with congenital adrenal hyperplasia.
- Published in:
- Clinical Endocrinology, 2018, v. 88, n. 6, p. 813, doi. 10.1111/cen.13580
- By:
- Publication type:
- Article
1117-P: Characterizing Glucose/C-Peptide Response Curve (GCRC) Phenotypes to Enhance Selection Specificity for Type 1 Diabetes (T1D) Prevention Trials.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1117-P
- By:
- Publication type:
- Article
75-OR: Marked Heterogeneity in Nondiabetic, Autoantibody-Positive (Ab+) Individuals with Dysglycemia: Implications for Type 1 Diabetes (T1D) Staging.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-75-OR
- By:
- Publication type:
- Article
1618-P: Insulin Secretion Variability According to the Specific Type 1 Diabetes (T1D) Risk Predictor.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1618-P
- By:
- Publication type:
- Article
99-OR: An Inflection Point (IP) of C-Peptide (C-P) Decline during Progression to Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-99-OR
- By:
- Publication type:
- Article
348-OR: Metabolic Phenotype of Autoantibody Positive (AbPos) Long-Term Nonprogressors (LTNPs) to Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-348-OR
- By:
- Publication type:
- Article
1684-P: Using Index60 to Detect Heterogeneity and Identify Subpopulations with Characteristic Type 1 Diabetes (T1D) Profiles among Individuals with Normal Two-Hour Glucose Levels.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1684-P
- By:
- Publication type:
- Article
1678-P: Comparisons of Combined C-Peptide and Glucose Intermediate Endpoints for Identifying Individuals at Very High Risk for Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1678-P
- By:
- Publication type:
- Article
1355-P: HbA1c Trajectories from Time of Diagnosis in Youth with T1D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1355-P
- By:
- Publication type:
- Article
1344-P: Persistent ß-Cell Responsiveness in Children at High Risk for Type 1 Diabetes (T1D) Is Associated with Decreased Progression to T1D in the Diabetes Prevention Trial-Type 1 (DPT-1).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1344-P
- By:
- Publication type:
- Article
1343-P: A Comparison of C-Peptide and Glucose Responses between Children and Adolescents Who Progress to Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1343-P
- By:
- Publication type:
- Article
85-OR: Modifiers of C-Peptide Change during the Progression to Type 1 Diabetes (T1D) in the TrialNet Pathway to Prevention Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-85-OR
- By:
- Publication type:
- Article
84-OR: Index60 and 2-Hour Glucose Diagnostic Thresholds: Comparison of Type 1 Diabetes (T1D) Marker Profiles.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-84-OR
- By:
- Publication type:
- Article